Geir Øystein Andersen
Position: MD, PhD
Phone: +472119100
Email:
Projects:
1)Leaf (Safety and efficacy of levosimendan in patients with acute myocardial infarction complicated by symptomatic left ventricular failure)
2)Biobanking in patients with myocardial infarction (BAMI)
 

Author network for Geir Øystein Andersen by COREMINE medical


Publications 2017

Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
PubMed 28931920

Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
PubMed 28253327

Publications 2016

Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
Acta Anaesthesiol Scand, 60 (8), 1170-81
PubMed 27306254

Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
Crit Care, 20 (1), 314
PubMed 27716377

Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
Monocyte-derived circulating microparticles (CD14(+), CD14(+)/CD11b(+) and CD14(+)/CD142(+)) are related to long-term prognosis for cardiovascular mortality in STEMI patients
Int J Cardiol, 227, 876-881
PubMed 27915085

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
J Am Heart Assoc, 5 (6)
PubMed 27412895

Publications 2015

Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB (2015)
Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
Atherosclerosis, 243 (1), 204-10
PubMed 26402139

Limalanathan S, Eritsland J, Kløw NE, Abdelnoor M, Hoffmann P, Andersen GØ (2015)
Influence of ischemic postconditioning on myocardial dysfunction measured by speckle tracking echocardiography in patients with ST-elevation myocardial infarction
Int J Cardiol, 187, 459-61
PubMed 25846653

Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
Circ Cardiovasc Interv, 8 (10)
PubMed 26453688

Stær-Jensen H, Sunde K, Andersen GØ (2015)
The authors reply
Crit Care Med, 43 (3), e98
PubMed 25700077

Sunde K, Andersen GØ (2015)
Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission-not reliable enough to be true!
Eur Heart J, 37 (42), 3229-3231
PubMed 26516178

Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
PLoS One, 10 (3), e0115547
PubMed 25738589

Publications 2014

Andersen GØ (2014)
Circulatory shock
N Engl J Med, 370 (6), 583
PubMed 24499234

Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
PLoS One, 9 (11), e112359
PubMed 25390695

Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
J Am Heart Assoc, 3 (2), e000679
PubMed 24760962

Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014)
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart
Br J Pharmacol, 171 (23), 5169-81
PubMed 24547784

Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
Crit Care Med, 42 (11), 2401-8
PubMed 25072762

Publications 2013

Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
Eur J Heart Fail, 15 (5), 565-72
PubMed 23288914

Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
PLoS One, 8 (8), e71780
PubMed 23977143

Publications 2012

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
Increased circulating mitochondrial DNA after myocardial infarction
Int J Cardiol, 158 (1), 132-4
PubMed 22578950

Publications 2011

Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
PubMed 21270073

Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Diabetes, 60 (5), 1544-51
PubMed 21464440

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
BMC Endocr Disord, 11, 14
PubMed 21801387

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
J Thromb Haemost, 9 (8), 1468-74
PubMed 21624046

Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K (2011)
Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study
Resuscitation, 82 (9), 1186-93
PubMed 21636202

Publications 2010

Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2010)
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
Cardiovasc Diabetol, 9, 47
PubMed 20809989

Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J (2010)
Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study
Cardiology, 116 (2), 103-9
PubMed 20588018

Publications 2009

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
Cardiovasc Diabetol, 8, 6
PubMed 19183453

Publications 2008

Andersen GØ (2008)
Treatment of acute decompensated heart failure: harmful effects of high doses of loop diuretics?
Cardiology, 113 (1), 9-11
PubMed 18931491

Publications 2007

Vinge LE, Andressen KW, Attramadal T, Andersen GØ, Ahmed MS, Peppel K, Koch WJ, Freedman NJ, Levy FO, Skomedal T, Osnes JB, Attramadal H (2007)
Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function
Mol Pharmacol, 72 (3), 582-91
PubMed 17573483

Publications 2005

Andersen GØ, Eritsland J, Bjørnerheim R, Kløw NE, Jonassen A, Mangschau A (2005)
[Cardiogenic shock-- new therapeutic strategies]
Tidsskr Nor Laegeforen, 125 (10), 1318-21
PubMed 15909001

Publications 2004

Øie E, Vinge LE, Andersen GØ, Yndestad A, Krobert KA, Sandberg C, Ahmed MS, Haug T, Levy FO, Skomedal T, Attramadal H (2004)
RAMP2 and RAMP3 mRNA levels are increased in failing rat cardiomyocytes and associated with increased responsiveness to adrenomedullin
J Mol Cell Cardiol, 38 (1), 145-51
PubMed 15623431